Literature DB >> 12890682

Involvement of phospholipase D2 in lysophosphatidate-induced transactivation of platelet-derived growth factor receptor-beta in human bronchial epithelial cells.

Lixin Wang1, Rhett Cummings, Yutong Zhao, Andrius Kazlauskas, James K S Sham, Andrew Morris, Steve Georas, David N Brindley, Viswanathan Natarajan.   

Abstract

Lysophosphatidate (LPA) mediates multiple cellular responses via heterotrimeric G protein coupled LPA-1, LPA-2, and LPA-3 receptors. Many G protein-coupled receptors stimulate ERK following tyrosine phosphorylation of growth factor receptors; however, the mechanism(s) of transactivation of receptor tyrosine kinases are not well defined. Here, we provide evidence for the involvement of phospholipase D (PLD) in LPA-mediated transactivation of platelet-derived growth factor receptor-beta (PDGF-R beta). In primary cultures of human bronchial epithelial cells (HBEpCs), LPA stimulated tyrosine phosphorylation of PDGF-R beta and threonine/tyrosine phosphorylation of ERK1/2. The LPA-mediated activation of ERK and tyrosine phosphorylation of PDGF-R beta was attenuated by tyrphostin AG 1296, an inhibitor of PDGF-R kinase, suggesting transactivation of PDGF-R by LPA. Furthermore, LPA-, but not PDGF beta-chain homodimer-induced tyrosine phosphorylation of PDGF-R beta was partially blocked by pertussis toxin, indicating coupling of LPA-R(s) to Gi. Exposure of HBEpCs to LPA activated PLD. Butan-1-ol, which acts as an acceptor of phosphatidate generated by the PLD pathway, blocked LPA-mediated transactivation of PDGF-R beta. This effect was not seen with butan-3-ol, suggesting PLD involvement. The role of PLD1 and PLD2 in the PDGF-R beta transactivation by LPA was investigated by infection of cells with adenoviral constructs of wild type and catalytically inactive mutants of PLD. LPA activated both PLD1 and PLD2 in HBEpCs; however, infection of cells with cDNA for wild type PLD2, but not PLD1, increased the tyrosine phosphorylation of PDGF-R beta in response to LPA. Also, the LPA-mediated tyrosine phosphorylation of PDGF-R beta was attenuated by the catalytically inactive mutant mPLD2-K758R. Infection of HBEpCs with adenoviral constructs of wild type hPLD1, mPLD2, and the inactive mutants of hPLD1 and mPLD2 resulted in association of PLD2 wild type and inactive mutant proteins with the PDGF-R beta compared with PLD1. These results show for the first time that transactivation of PDGF-R beta by LPA in HBEpCs is regulated by PLD2.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12890682     DOI: 10.1074/jbc.M302896200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Expression profiles of the mouse lung identify a molecular signature of time-to-birth.

Authors:  Alvin T Kho; Soumyaroop Bhattacharya; Brigham H Mecham; Jungha Hong; Isaac S Kohane; Thomas J Mariani
Journal:  Am J Respir Cell Mol Biol       Date:  2008-07-29       Impact factor: 6.914

2.  Regulation of lysophosphatidic acid-induced epidermal growth factor receptor transactivation and interleukin-8 secretion in human bronchial epithelial cells by protein kinase Cdelta, Lyn kinase, and matrix metalloproteinases.

Authors:  Yutong Zhao; Donghong He; Bahman Saatian; Tonya Watkins; Ernst Wm Spannhake; Nigel J Pyne; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2006-05-10       Impact factor: 5.157

Review 3.  Lysophosphatidic acid (LPA) and its receptors: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Biochim Biophys Acta       Date:  2012-07-15

4.  Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation.

Authors:  Gye Young Park; Yong Gyu Lee; Evgeny Berdyshev; Sharmilee Nyenhuis; Jian Du; Panfeng Fu; Irina A Gorshkova; Yongchao Li; Sangwoon Chung; Manjula Karpurapu; Jing Deng; Ravi Ranjan; Lei Xiao; H Ari Jaffe; Susan J Corbridge; Elizabeth A B Kelly; Nizar N Jarjour; Jerold Chun; Glenn D Prestwich; Eleanna Kaffe; Ioanna Ninou; Vassilis Aidinis; Andrew J Morris; Susan S Smyth; Steven J Ackerman; Viswanathan Natarajan; John W Christman
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

Review 5.  Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.

Authors:  Yutong Zhao; Viswanathan Natarajan
Journal:  Cell Signal       Date:  2008-10-26       Impact factor: 4.315

Review 6.  Lysophosphatidic acid and autotaxin: emerging roles in innate and adaptive immunity.

Authors:  Steve N Georas
Journal:  Immunol Res       Date:  2009-01-30       Impact factor: 2.829

7.  Lysophosphatidic acid-induced transactivation of epidermal growth factor receptor regulates cyclo-oxygenase-2 expression and prostaglandin E(2) release via C/EBPbeta in human bronchial epithelial cells.

Authors:  Donghong He; Viswanathan Natarajan; Randi Stern; Irina A Gorshkova; Julian Solway; Ernst Wm Spannhake; Yutong Zhao
Journal:  Biochem J       Date:  2008-05-15       Impact factor: 3.857

8.  Lysophosphatidic acid induces interleukin-13 (IL-13) receptor alpha2 expression and inhibits IL-13 signaling in primary human bronchial epithelial cells.

Authors:  Yutong Zhao; Donghong He; Jing Zhao; Lixin Wang; Alan R Leff; Ernst Wm Spannhake; Steve Georas; Viswanathan Natarajan
Journal:  J Biol Chem       Date:  2007-02-06       Impact factor: 5.157

9.  A transgenic mouse with vascular endothelial over-expression of the non-muscle myosin light chain kinase-2 isoform is susceptible to inflammatory lung injury: role of sexual dimorphism and age.

Authors:  Jaideep Moitra; Carrie Evenoski; Saad Sammani; Raj Wadgaonkar; Jerrold R Turner; Shwu Fan Ma; Joe G N Garcia
Journal:  Transl Res       Date:  2008-01-18       Impact factor: 7.012

10.  Phospholipase D signaling in serotonin-induced mitogenesis of pulmonary artery smooth muscle cells.

Authors:  Y Liu; B L Fanburg
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.